PTEN and cancer: In cancer, the activity of SHIP1 and SH2-containing inositol 5′-polyphosphatases (SHIP2) and 3-phosphatase tensin homolog (PTEN) is generally considered as a negative regulator of the PI3K axis by reducing the PI(3,4,5)P3 levels at the plasma membrane.